Cargando…
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 – Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial
OBJECTIVES: To determine if a specific immunomodulatory intervention reduces progression of COVID-19-related disease to organ failure or death, compared to standard of care (SoC). TRIAL DESIGN: Randomised, parallel 3-arm (1:1:1 ratio), open-label, Phase IV platform trial of immunomodulatory therapie...
Autores principales: | Kulkarni, Spoorthy, Fisk, Marie, Kostapanos, Michalis, Banham-Hall, Edward, Bond, Simon, Hernan-Sancho, Elena, Norton, Sam, Cheriyan, Joseph, Cope, Andrew, Galloway, James, Hall, Frances, Jayne, David, Wilkinson, Ian B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341462/ https://www.ncbi.nlm.nih.gov/pubmed/32641154 http://dx.doi.org/10.1186/s13063-020-04535-4 |
Ejemplares similares
-
muLTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19-Experimental drugs and mechanisms (TACTIC-E): A structured summary of a study protocol for a randomized controlled trial
por: Lu, Ing Ni, et al.
Publicado: (2020) -
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trial
por: Hall, Frances C, et al.
Publicado: (2023) -
Pre-ICU length of hospital stay is a predictor of hospital but not ICU mortality
por: Flavin, K, et al.
Publicado: (2015) -
Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022) -
Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML
por: James, Jenna R., et al.
Publicado: (2023)